Funder
Alkek Center for Molecular Discovery and Metabolomics
National Institutes of Health
Welch Foundation
Cancer Prevention and Research Institute of Texas
Subject
Pharmacology,Biochemistry
Reference43 articles.
1. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development;de Bodinat;Nat. Rev. Drug Discov.,2010
2. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways;Millan;J. Pharmacol. Exp. Ther.,2003
3. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder;Olie;Int. J. Neuropsychopharmacol.,2007
4. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action;Kasper;World J. Biol. Psychiatry,2009
5. Novel naphthalenic ligands with high affinity for the melatonin receptor;Yous;J. Med. Chem.,1992
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献